amifostine anhydrous has been researched along with Invasiveness, Neoplasm in 3 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a series of patients with bladder cancer treated with hypofractionated accelerated radiotherapy with amifostine cytoprotection, with or without concurrent liposomal doxorubicin." | 1.34 | Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer. ( Koukourakis, MI; Touloupidis, S; Tsolos, C, 2007) |
| " Nontumor-bearing control animals were sham treated using the same dosing and surgery schedules." | 1.31 | Inhibition of spontaneous metastases formation by amifostine. ( Grdina, DJ; Hunter, N; Kataoka, Y; Milas, L; Murley, JS; Weichselbaum, RR, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amrein, PC | 1 |
| Clark, JR | 1 |
| Supko, JG | 1 |
| Fabian, RL | 1 |
| Wang, CC | 1 |
| Colevas, AD | 1 |
| Posner, MR | 1 |
| Deschler, DG | 1 |
| Rocco, JW | 1 |
| Finkelstein, DM | 1 |
| McIntyre, JF | 1 |
| Koukourakis, MI | 1 |
| Tsolos, C | 1 |
| Touloupidis, S | 1 |
| Grdina, DJ | 1 |
| Kataoka, Y | 1 |
| Murley, JS | 1 |
| Hunter, N | 1 |
| Weichselbaum, RR | 1 |
| Milas, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase I/II Study of Escalating Doses of Taxol Used Concurrently With Ethyol and Accelerated Hyperfractionated Radiotherapy in the Treatment of Stage III and IV Carcinoma of the Head and Neck[NCT00003193] | Phase 1/Phase 2 | 37 participants (Anticipated) | Interventional | 1998-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for amifostine anhydrous and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma.
Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modal | 2005 |
2 other studies available for amifostine anhydrous and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
Topics: Aged; Aged, 80 and over; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; | 2007 |
Inhibition of spontaneous metastases formation by amifostine.
Topics: Amifostine; Angiostatins; Animals; Blotting, Western; Cell Division; Dose-Response Relationship, Dru | 2002 |